THE WHAT? DSM-Firmenich has announced the launch of its inaugural €800 million bond with a 10-year maturity due in 2034 at a coupon of 3.625 percent. The bond will be issued by DSM and guaranteed by DSM-Firmenich under the cross-guarantee structure.
THE DETAILS The re-offer price for the 10-year bond tranche was 99.456 percent. Based on this price, the yield is 3.691 percent. The bonds will be listed on the Luxembourg Stock Exchange shortly.
THE WHY? The proceeds will be used for general corporate purposes, DSM-Firmenich said, including the refinancing of existing debt.
Clinical aesthetics products refer to a category of products used in the field of medical aesthetics or cosmetic dermatology. These products are typically designed and formulated to be used under the supervision of healthcare professionals, such as dermatologists, plastic surgeons, or trained aestheticians. They are distinct from over-the-counter cosmetics in that they often contain active ingredients or formulations that require expertise in their application or administration.
Examples of clinical aesthetics products include:
-
Dermal Fillers: Injectable substances used to add volume, smooth wrinkles, and enhance facial contours. Examples include hyaluronic acid fillers like Juvederm and Restylane.
-
Botulinum Toxin (Botox): Injectables that temporarily paralyze facial muscles to reduce the appearance of wrinkles caused by repetitive movements, such as frown lines and crow's feet.
-
Chemical Peels: Solutions applied to the skin to exfoliate and improve its texture. They can treat acne, pigmentation issues, and signs of aging.
-
Laser and Light Therapies: Devices that emit focused light or laser energy to treat various skin conditions, including acne, scars, and signs of aging.
-
Prescription Skincare Products: Formulations containing active ingredients like retinoids (vitamin A derivatives), hydroquinone, or prescription-strength antioxidants to address specific skin concerns under medical supervision.
